{"id":790840,"date":"2024-11-26T09:10:22","date_gmt":"2024-11-26T14:10:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/"},"modified":"2024-11-26T09:10:22","modified_gmt":"2024-11-26T14:10:22","slug":"geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/","title":{"rendered":"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference"},"content":{"rendered":"
\n

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 – the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference taking place December 2-5, 2024 in Boca Raton, FL.<\/p>\n\n\n\n\n\n\n
\n Presentation Details:<\/b>\n <\/td>\n<\/tr>\n
\n Speaker:<\/b>\n <\/td>\n\u00a0<\/td>\nDavid Dodd, Chairman & CEO<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Date\/Time:<\/b>\n <\/td>\n\u00a0<\/td>\nDecember 3, 2024, 11:30 am ET<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Location:<\/b>\n <\/td>\n\u00a0<\/td>\nFlorida Atlantic University Executive Education Complex, Boca Raton, FL<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Title:<\/b>\n <\/td>\n\u00a0<\/td>\nGeoVax Corporate Update<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

A high-definition video webcast of the presentation will be available the following day on the Company’s website www.geovax.com<\/a>, and as part of a complete catalog of presentations available at Noble Capital Markets\u2019 Conference website: www.nobleconference.com<\/a> and on Channelchek: www.channelchek.com<\/a> the investor portal created by Noble. The webcast will be archived on the company’s website, the NobleCon website, and on Channelchek.com for 90 days following the event. Senior GeoVax management will also host one-on-one meetings with registered attendees.<\/p>\n

About GeoVax<\/p>\n

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world\u2019s most threatening infectious diseases and therapies for solid tumor cancers. The company\u2019s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin\u00ae, having recently completed a multicenter Phase 1\/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin\u00ae combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com<\/a>.<\/p>\n\n\n\n\n
\n Company Contact:<\/b>\n <\/td>\n\u00a0<\/td>\n\n Investor Relations Contact:<\/b>\n <\/td>\n\u00a0<\/td>\n\n Media Contact:<\/b>\n <\/td>\n<\/tr>\n
\n
\n info@geovax.com<\/a>
\n <\/u>\n <\/td>\n		\u00a0<\/td>\n\n austin.murtagh@precisionaq.com<\/u>\n <\/td>\n\u00a0<\/td>\n\n
\n sr@roberts-communications.com <\/a>
\n <\/u>\n <\/td>\n<\/tr>\n
678-384-7220<\/td>\n\u00a0<\/td>\n212-698-8696<\/td>\n\u00a0<\/td>\n202-779-0929<\/td>\n<\/tr>\n<\/table>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 – the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference taking place December 2-5, 2024 in Boca Raton, FL. Presentation Details: Speaker: \u00a0 David Dodd, Chairman & CEO \u00a0 Date\/Time: \u00a0 December 3, 2024, 11:30 am ET \u00a0 Location: \u00a0 Florida Atlantic University Executive Education Complex, Boca Raton, FL \u00a0 Title: \u00a0 GeoVax Corporate Update \u00a0 A high-definition video webcast of the presentation will be available the following day on the Company’s website www.geovax.com, and as part of a complete catalog of presentations … <\/p>\n

Continue reading “GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-790840","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 – the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference taking place December 2-5, 2024 in Boca Raton, FL. Presentation Details: Speaker: \u00a0 David Dodd, Chairman & CEO \u00a0 Date\/Time: \u00a0 December 3, 2024, 11:30 am ET \u00a0 Location: \u00a0 Florida Atlantic University Executive Education Complex, Boca Raton, FL \u00a0 Title: \u00a0 GeoVax Corporate Update \u00a0 A high-definition video webcast of the presentation will be available the following day on the Company’s website www.geovax.com, and as part of a complete catalog of presentations … Continue reading "GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-26T14:10:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference\",\"datePublished\":\"2024-11-26T14:10:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/\"},\"wordCount\":459,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/\",\"name\":\"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==\",\"datePublished\":\"2024-11-26T14:10:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/","og_locale":"en_US","og_type":"article","og_title":"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - Market Newsdesk","og_description":"ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 – the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference taking place December 2-5, 2024 in Boca Raton, FL. Presentation Details: Speaker: \u00a0 David Dodd, Chairman & CEO \u00a0 Date\/Time: \u00a0 December 3, 2024, 11:30 am ET \u00a0 Location: \u00a0 Florida Atlantic University Executive Education Complex, Boca Raton, FL \u00a0 Title: \u00a0 GeoVax Corporate Update \u00a0 A high-definition video webcast of the presentation will be available the following day on the Company’s website www.geovax.com, and as part of a complete catalog of presentations … Continue reading \"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-11-26T14:10:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference","datePublished":"2024-11-26T14:10:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/"},"wordCount":459,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/","name":"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==","datePublished":"2024-11-26T14:10:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3NzQzMiM2NTkzNTMyIzUwMDAzMjA1NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-present-at-the-noble-capital-markets-twentieth-annual-emerging-growth-equity-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=790840"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790840\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=790840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=790840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=790840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}